Big Announcement Alert: Discoveries meet momentum. Right here.

Fitzsimon_menu

Eye on innovators.

Each month, we feature an innovator who is making advances in health and care through the work they do here on the Fitzsimons Innovation Community campus.

THIS MONTH’S FEATURE

Demonstrating Community Momentum

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcase groundbreaking research and innovations in the region. Learn more about the 2022 presenting companies from our Community who share a passion for taking their research to the next level to improve care, cure diseases, and save lives.
Read More

Previous Innovation Spotlights:

Demonstrating Community Momentum
September 26, 2022

Demonstrating Community Momentum

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcase groundbreaking research and innovations in the region. Learn more about the 2022 presenting companies from our Community who share a passion for taking their research to the next level to improve care, cure diseases, and save lives.

READ MORE

Test
September 23, 2022

Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip...

READ MORE

InVitria
August 30, 2022

InVitria

InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in emerging advanced treatments like cell therapies, gene therapies, and the new generation of vaccines.

READ MORE

Invenux
June 24, 2022

Invenux

Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a botanical medicine approach, Invenux aims to break down barriers to save and change the lives of sickle cell disease patients.

READ MORE

Validus
May 27, 2022

Validus

Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for oncology patients, and researchers at Colorado State University and the CU Anschutz Medical Campus discovered stem cells can also be activated to fight infections.

READ MORE

Atara Biotherapeutics
April 26, 2022

Atara Biotherapeutics

Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.

READ MORE